Sarepta Therapeutics to Announce Fourth Quarter and Full-Year 2025 Financial Results
Affected assets and topics
Why it matters
Sarepta Therapeutics will announce its Q4 and full-year 2025 financial results on February 25, 2026, following the Nasdaq close, and host a conference call at 4:30 p.m. E.T. to discuss the results.
Article tone
Expected market reaction
Market impact analysis based on neutral sentiment with 75% confidence.
Evidence trail
Evidence
AI provenance
Technical identifiers
- Provider tag
- groq-llama-3.1-8b-instant
- Analysis version
- groq-llama-3.1-8b-instant
- Article id
- 44491
- Timeframe
- 6h
Prediction lifecycle
-
Llama 3.1 8B Instant (Groq) NASDAQ Neutral 75%Generated 6h Excluded
Expired: not evaluated within 7 days of its 6h timeframe elapsing
Logged at publication, scored automatically once the window closes — never edited.
Original source
CAMBRIDGE, Mass., February 11, 2026--Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, will report fourth quarter and full-year 2025 financial results after the Nasdaq Global Market closes on Wednesday, Feb. 25, 2026. Subsequently, at 4:30 p.m. E.T., the Company will host a conference call to discuss its fourth quarter and full-year 2025 financial results.
Read the full article on Yahoo Finance
Original article published by Yahoo Finance on February 11, 2026. Analysis and insights provided by AnalystMarkets AI.